华西医学

华西医学

不同关节腔注射方法治疗早期冻结肩疗效与安全性分析

查看全文

目的 比较双腔注射复方倍他米松、罗哌卡因及玻璃酸钠与单腔注射治疗早期冻结肩的疗效和安全性。 方法 2015 年 5 月—2017 年 5 月纳入 68 例早期冻结肩患者并随机分为双腔注射组和单腔注射组,每组各 34 例。双腔注射组分别于盂肱关节腔注射复方倍他米松注射液 1 mL+玻璃酸钠 2 mL+罗哌卡因 6 mL+生理盐水 8 mL,肩峰下注射倍他米松注射液 1 mL+玻璃酸钠 2 mL+生理盐水 2 mL+罗哌卡因 2 mL;单腔注射组仅在盂肱关节腔注射与双腔注射组相同剂量的药物。给药后 3、6、12 周门诊随访,采用视觉模拟评分(Visual Analogue Scale,VAS)量表和 Constant-Murley 肩功能评分量表分别评估疼痛程度和肩功能,采用其治疗前后差值评估疼痛缓解程度和肩功能改善情况。 结果 68 例患者中 63 例完成随访,两组各 2 例失访,双腔注射组 1 例退出试验。两组治疗前后比较,疼痛评分降低,肩功能评分升高,差异有统计学意义(P<0.001)。单腔注射组治疗后 6、12 周与治疗后 3 周比较,疼痛缓解(ΔVAS)明显,差异有统计学意义(P<0.001),但治疗后 6 周与 12 周比较,差异无统计学意义(P=0.354)。双腔注射组治疗后 3、6、12 周两两比较,疼痛缓解明显,差异有统计学意义(3 周 vs. 6 周:P<0.001;3 周vs. 12 周:P<0.001;3 周vs. 6 周:P=0.034)。各组肩功能在治疗后 3、6、12 周明显改善,各时间点两两比较差异均有统计学意义(P<0.001)。组间比较:两组间疼痛缓解(P=0.386)、肩功能改善(P=0.685)差异均无统计学意义。相同时间点两组间疼痛缓解(治疗后 3 周:P=0.898;6 周:P=0.448;12 周:P=0.216)和肩功能改善(治疗后 3 周:P=0.120;6 周:P=0.152;12 周:P=0.868)差异均无统计学意义。 结论 不同注射方法均能有效缓解早期冻结肩疼痛和改善肩功能,且耐受性好。但尚未发现双腔注射法的临床疗效和安全性优于单腔注射法。

Objective To evaluate the efficacy and safety of different site injection of compound betamethasone injection, ropivacaine and sodium hyaluronate for treatment of frozen shoulder at early stage. Methods A Total of 68 participants were included from May 2015 to May 2017 and randomly assigned to the glenohumeral joint and subacromial space group (IA+SA group, n=34) and glenohumeral joint group (IA group, n=34). In the IA+SA group, a solution of 1 mL corticosteroid, 6 mL ropivacaine, 2 mL sodium hyaluronate, and 8 mL normal saline were prepared and injected to glenohumeral joint, and a solution of 1 mL corticosteroid, 2 mL ropivacaine, 2 mL sodium hyaluronate, and 2 mL normal saline were injected to subacromial space. In the IA group, participants were given the same dose of drugs to the glenohumeral joint. The Visual Analogue Scale (VAS) score and Constant-Murley score were used to assess pain and function of shoulder respectively. The change of VAS score and Constant-Murley score after treatment were used to evaluate pain relief and shoulder function improvement. Results Of the 68 participants, two in each group were lost to follow up and one in the IA+SA group dropped out. There was significant effect on pain relief and shoulder function improvement on all measurement in both groups (P<0.001) during the 12 weeks after treatment. In the IA group, group- by-time interaction were significant for pain relief at 6 and 12 weeks comparing with that at 3 weeks (P<0.001), while no significant difference at 6 weeks comparing with 12 weeks. In the IA+SA group, group-by-time interaction were significant for pain relief at all endpoints (3 weeksvs. 6 weeks: P<0.001; 3 weeksvs. 12 weeks: P<0.001; 3 weeksvs. 6 weeks: P=0.034). In both groups, there was significant effect on shoulder function improvement when compared at each endpoint within group (P<0.001). Between-group comparison revealed no significant effect on pain relief (P=0.386) or shoulder function improvement (P=0.685). There was also no significant effect on pain relief (3 weeks: P=0.898; 6 weeks: P=0.448; 12 weeks: P=0.216) and shoulder function improvement (3 weeks: P=0.120; 6 weeks: P=0.152; 12 weeks: P=0.868) at each same endpoint. Conclusions Different site injection can effectively release pain and improve shoulder function for the patients with frozen shoulder at early stage and be well tolerated. However, it is not found that two site injection is inferior to single site injection.

关键词: 盂肱关节腔注射; 双腔注射; 单腔注射; 冻结肩; 临床观察

Key words: Glenohumeral joint injection; Two side injection; Single side injection; Frozen shoulder; Clinical study

引用本文: 蒋勰, 陈志超, 黄华强, 顾祖超. 不同关节腔注射方法治疗早期冻结肩疗效与安全性分析. 华西医学, 2018, 33(12): 1495-1499. doi: 10.7507/1002-0179.201811034 复制

登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. New Zealand Guidelines Group. The diagnosis and management of soft tissue shoulder injuries and related disorders. Wellington: New Zealand Guidelines Group. http://www.nzgg.org.nz.
2. Bunker TD, Anthony PP. The pathology of frozen shoulder. J Bone Joint Surg, 1995, 77B(5): 677-683.
3. Tamai K, Akutsu M, Yano Y. Primary frozen shoulder: brief review of pathology and imaging abnormalities. J Orthop Sci, 2014, 19(1): 1-5.
4. Guyver PM, Bruce DJ, Rees JL. Frozen shoulder-a stiff problem that requires a flexible approach. Maturitas, 2014, 78(1): 1l-16.
5. Neviaser AS, Hannafin JA. Adhesive capsulitis: a review of current treatment. Am J Sports Med, 2010, 38(11): 2346-2356.
6. Hagiwara Y, Sugaya H, Takahashi N, et al. Effects of intra: articular steroid injection before pan-capsular release in patients with refractory frozen shoulder. Knee Surg Sports Traumatol Arthrose, 2015, 23(5): 1536-1541.
7. Shaffer B, Tibone JE, Kerlan RK. Frozen shoulder. A long-term follow-up. J Bone Joint Surg (Am), 1992, 74(5): 738-746.
8. Constant CR, Murley AH. A clinical method of functional assessment of the shoulder. Clin Orthop Relat Res, 1987, 214(2): 160-164.
9. Kirkley A, Griffin S, Dainty K. Scoring systems for the functional assessment of the shoulder. Arthroscopy, 2003, 19(10): 1109-1120.
10. Hand C, Clipsham K, Rees JL, et al. Long-term outcome of frozen shoulder. J Shoulder Elbow Surg, 2008, 17(2): 231-236.
11. Mengiardi B, Pfirrmann CW, Gerber C, et al. Frozen shoulder: MR arthrographic findings. Radiology, 2004, 233(2): 486-492.
12. Lorbach O, Anagnostakos K, Scherf C, et al. Nonoperative management of adhesive capsulitis of the shoulder: oral cortisone application versus intra-articular cortisone injections. J Shoulder Elbow Surg, 2010, 19(2): 172-179.
13. Van der Windt DA, Koes BW, Deville W, et al. Effectiveness of corticosteroid injections versus physiotherapy for treatment of painful stiff shoulder in primary care: randomised trial. BMJ, 1998, 317(7168): 1292-1296.
14. Moreland LW. Intra articular hyaluronan (hyduronic acid) and hylans for the treatment of osteoarvhritis: mechanisms of action. Arthritis Res Ther, 2003, 5(2): 54-67.
15. Saito S, Furuya T, Kotake S. Therapeutic effects of hyaluronate injections in patients with chronic painful shoulder: a meta-analysis of randomized controlled trials. Arthritis Care Res (Hoboken), 2010, 62(7): 1009-1018.
16. Smet l, Vlaminck E, Vercauteren M. Randomized controlled trial of patient-controlled epidural analgesia after orthopaedic surgery with sufentanil and ropivacaine 0.165% or levobupivacaine 0.125%. Br J Anaesth, 2008, 100(1): 99-103.
17. 李建国. 罗哌卡因的药理学特性及临床应用进展. 中国基层医药, 2012, 19(2): 292-294.
18. Carette S, Moffet H, Tardif J, et al. Intraarticular corticosteroids, supervised physiotherapy, or a combination of the two in the treatment of adhesive capsulitis of the shoulder: a placebo-controlled trial. Arthritis Rheum, 2003, 48(3): 829-838.
19. Prestgaard T, Wormgoor ME, Haugen SA, et al. Ultrasound-guided intra-articular and rotator interval corticosteroid injections in adhesive capsulitis of the shoulder: a double-blind, sham-controlled randomized study. Pain, 2015, 156(9): 1683-1691.
20. Cho CH, Kim DH, Bae KC, et al. Proper site of corticosteroid injection for the treatment of idiopathic frozen shoulder: results from a randomized trial. Joint Bone Spine, 2016, 83(3): 324-329.